Mark S. Pilarczyk, PA-C

Mark Pilarczyk practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Mark Pilarczyk's NPI, 1780773101, was assigned on October 12, 2006. Mark Pilarczyk holds Texas license PA04380.

Mark Pilarczyk's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Mark Pilarczyk's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Pilarczyk practices. Vendor and product names are available with a free account.

Physician assistant is Mark Pilarczyk's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Mark Pilarczyk is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Mark Pilarczyk is licensed in Texas.

CMS data shows 155 Medicare services from Mark Pilarczyk across 4 procedure codes in 2024, for 95 Medicare patients. Medicare paid $8,018 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 95 Medicare patients who saw Mark Pilarczyk in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 3.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mark Pilarczyk's median patient age at 64, with 54% women.

In 2024, Mark Pilarczyk wrote 68 Medicare Part D claims for 24 patients. 90% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Mark Pilarczyk for performance year 2024, reported as part of a group. Mark Pilarczyk accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Mark Pilarczyk from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Ethicon Inc. paid the most, $32.